Precision Historical Cash Flow
| DTIL Stock | USD 5.51 0.04 0.73% |
Analysis of Precision BioSciences cash flow over time is an excellent tool to project Precision BioSciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 342.9 K or Depreciation of 6.5 M as it is a great indicator of Precision BioSciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Precision BioSciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Precision BioSciences is a good buy for the upcoming year.
Precision |
About Precision Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Precision balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Precision's non-liquid assets can be easily converted into cash.
Precision BioSciences Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Precision BioSciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Precision BioSciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Precision BioSciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Precision BioSciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.At this time, Precision BioSciences' Cash And Cash Equivalents Changes is quite stable compared to the past year.
| 2024 | 2025 (projected) | Dividends Paid | 11.2M | 9.9M | Depreciation | 9.5M | 6.5M |
Precision BioSciences cash flow statement Correlations
Click cells to compare fundamentals
Precision BioSciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Precision BioSciences cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 136.4M | 689K | 67.3M | 74.7M | 85.9M | 43.7M | |
| Change In Cash | (91.1M) | 53.9M | 45.9M | (72.9M) | (65.6M) | (62.3M) | |
| Total Cashflows From Investing Activities | (24.7M) | (5.0M) | (5.8M) | (3.3M) | (3.8M) | (4.0M) | |
| Other Cashflows From Financing Activities | 1.3M | 7.6M | 835K | 401K | 360.9K | 342.9K | |
| Depreciation | 9.8M | 10.2M | 9.0M | 8.3M | 9.5M | 6.5M | |
| Capital Expenditures | 5.0M | 5.8M | 3.3M | 2.3M | 2.1M | 1.9M | |
| Total Cash From Operating Activities | (87.4M) | (10.9M) | (45.8M) | (84.1M) | (75.7M) | (71.9M) | |
| Change To Account Receivables | (9.0M) | 9.5M | (232K) | (181K) | (208.2K) | (218.6K) | |
| Change To Operating Activities | 5.3M | 6.7M | 2.4M | (3.2M) | (3.6M) | (3.5M) | |
| Net Income | (109.0M) | (30.6M) | (111.6M) | (61.3M) | (55.2M) | (57.9M) | |
| Total Cash From Financing Activities | 1.3M | 70.5M | 95.0M | 5.4M | 6.2M | 5.9M | |
| End Period Cash Flow | 89.8M | 143.7M | 189.6M | 116.7M | 134.2M | 134.8M | |
| Change To Netincome | 18.9M | 13.8M | (10.1M) | 32.8M | 37.8M | 39.6M | |
| Change To Liabilities | (7.2M) | 326K | 867K | 153K | 137.7K | 130.8K | |
| Investments | (5.0M) | (5.8M) | (3.3M) | 5.2M | 5.9M | 6.2M | |
| Stock Based Compensation | 13.8M | 16.5M | 19.2M | 14.0M | 16.1M | 11.8M | |
| Free Cash Flow | (92.4M) | (16.7M) | (49.1M) | (86.4M) | (77.8M) | (81.6M) | |
| Change In Working Capital | (2.0M) | 19.6M | 24.1M | (41.5M) | (37.3M) | (35.5M) | |
| Begin Period Cash Flow | 180.9M | 89.8M | 143.7M | 189.6M | 218.0M | 135.7M | |
| Other Non Cash Items | 35K | (20.4M) | 13.6M | (3.6M) | (3.2M) | (3.1M) | |
| Issuance Of Capital Stock | 35M | 60.5M | 74.3M | 2.2M | 1.9M | 1.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share | Quarterly Revenue Growth (0.96) | Return On Assets | Return On Equity |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.